Vama Lifecare Private Limited — Mitomycin Exporter Profile
Indian Pharmaceutical Exporter · #8 for Mitomycin · $70.1K export value · DGFT Verified
Vama Lifecare Private Limited is the #8 Indian exporter of Mitomycin with $70.1K in export value and 22 verified shipments. Vama Lifecare Private Limited holds a 0.9% market share in Mitomycin exports across 5 countries. The company exports 14 pharmaceutical products worth $1.4M across 3 therapeutic categories.
Vama Lifecare Private Limited — Mitomycin Export Profile: Buyers & Destinations
Where Does Vama Lifecare Private Limited Export Mitomycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| POLAND | $53.7K | 6 | 76.6% |
| UNITED ARAB EMIRATES | $8.9K | 7 | 12.7% |
| KENYA | $6.8K | 4 | 9.7% |
| SRI LANKA | $627 | 3 | 0.9% |
| BRAZIL | $88 | 2 | 0.1% |
Vama Lifecare Private Limited exports Mitomycin to 5 countries. The largest destination is POLAND accounting for 76.6% of Vama Lifecare Private Limited's Mitomycin shipments, followed by UNITED ARAB EMIRATES (12.7%) and KENYA (9.7%). These destinations reflect Vama Lifecare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Mitomycin from Vama Lifecare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AS PER INVOICE POLAND | POLAND | $50.9K | 3 |
| AS PER INVOICE UNITED ARAB EMIRATE | UNITED ARAB EMIRATES | $8.9K | 7 |
| AS PER INVOICE KENYA | KENYA | $2.9K | 1 |
| EXP CODE | POLAND | $2.8K | 4 |
| AS PER INVOICE | KENYA | $2.7K | 1 |
| TO THE | KENYA | $1.4K | 5 |
| AS PER INVOICE SRI LANKA | SRI LANKA | $591 | 1 |
Vama Lifecare Private Limited supplies Mitomycin to 7 buyers globally. The largest buyer is AS PER INVOICE POLAND (POLAND), followed by AS PER INVOICE UNITED ARAB EMIRATE (UNITED ARAB EMIRATES) and AS PER INVOICE KENYA (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Mitomycin Export Value and How Much Does Vama Lifecare Private Limited Contribute?
India exported $5.6M worth of Mitomycin through 1,333 shipments from 213 suppliers to 103 countries, serving 456 buyers globally. Vama Lifecare Private Limited contributes $70.1K to this total, accounting for 0.9% of India's Mitomycin exports. Vama Lifecare Private Limited ships Mitomycin to 5 countries through 7 buyers.
What Is the Average Shipment Value for Vama Lifecare Private Limited's Mitomycin Exports?
Vama Lifecare Private Limited's average Mitomycin shipment value is $3.2K per consignment, based on 22 shipments totaling $70.1K. The largest destination is POLAND (76.6% of Vama Lifecare Private Limited's Mitomycin exports).
How Does Vama Lifecare Private Limited Compare to Other Indian Mitomycin Exporters?
Vama Lifecare Private Limited ranks #8 among 213 Indian Mitomycin exporters with a 0.9% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($2.3M), MYLAN LABORATORIES LIMITED ($1.3M), NAPROD LIFE SCIENCES PRIVATE LIMITED ($738.6K). Vama Lifecare Private Limited processed 22 shipments to 5 destination countries.
What Mitomycin Formulations Does Vama Lifecare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION MITOMYCIN FOR INJECTION USP 20MG/VIAL (VITOMYCIN 20MG/VIAL) BATCH NUM | $47.9K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION MITOMYCIN FOR INJECTION USP 20MG VIAL BATCH NUMBER OL0946 MANUFAC | $6.4K | 3 |
| * HARMLESS MEDICINE FOR HUMAN CONSUMPTION MITOMYCIN INJECTION IP 40MG BATCH NUMBER.: NN4240A MANUFACTURING DA | $2.9K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ. MITOMYCIN 40MG BATCH NO. NN3475AMFG DATE. 09/2023 EXP DATE. 05/2026NOS | $2.7K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION MITOMYCIN INJECTION IP 10 MGBATCH NUMBER.: NN4379A MANUFACTURING DAT | $2.5K | 1 |
| * HARMLESS MEDICINE FOR HUMAN CONSUMPTION MITOMYCIN INJECTION IP 40MG BATCH NUMBER.: NN4144A MANUFACTURING DA | $1.6K | 2 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ. MITOMYCIN 10MG BATCH NO. NN2536A MANUFACTURING DATE. 12/2022 EXP DATE. 09/2025 | $1.6K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ MITOMYCIN 10MG INJ MITOMYCIN C 10MG BATCH NO NN2471A MFG DATE 10 20 | $1.3K | 2 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ. MITOMYCIN 10MG BATCH NO. NN3109A MANUFACTURING DATE. 03/2023 EXP DATE. 07/2025 | $1.1K | 1 |
| * HARMLESS MEDICINE FOR HUMAN CONSUMPTION MITOMYCIN INJECTION IP 40MG BATCH NUMBER.: NN4217A MANUFACTURING DA | $1.0K | 1 |
Vama Lifecare Private Limited exports 18 distinct Mitomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINE FOR HUMAN CONSUMPTION MITOMYCIN FOR INJECT with 1 shipments worth $47.9K.
How Does Vama Lifecare Private Limited Compare to Nearest Mitomycin Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | EUGIA PHARMA SPECIALITIES LIMITED | $329.1K | 8 | 1 | $41.1K |
| 7 | AXA PARENTERALS LIMITED | $88.4K | 3 | 1 | $29.5K |
| 8 | VAMA LIFECARE PRIVATE LIMITED ★ | $70.1K | 22 | 5 | $3.2K |
| 9 | DISTINCT IMPEX PRIVATE LIMITED | $50.7K | 9 | 2 | $5.6K |
| 10 | DHEER HEALTH CARE PRIVATE LIMITED | $44.3K | 5 | 1 | $8.9K |
Vama Lifecare Private Limited ranks #8 among 213 Indian Mitomycin exporters. Average shipment value of $3.2K compared to the market average of $26.4K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and AXA PARENTERALS LIMITED.
Which Indian Ports Ship Mitomycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 341 | 25.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 261 | 19.6% |
| Bombay Air | 104 | 7.8% |
| DELHI AIR | 91 | 6.8% |
| DELHI AIR CARGO ACC (INDEL4) | 72 | 5.4% |
| AHEMDABAD AIR ACC (INAMD4) | 62 | 4.7% |
| AHEMDABAD AIR | 55 | 4.1% |
| Bombay Air Cargo | 43 | 3.2% |
What Other Advanced Oncology Products Does Vama Lifecare Private Limited Export?
Vama Lifecare Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About Vama Lifecare Private Limited
Vama Lifecare Private Limited exports 14 products worth $1.4M. Beyond Mitomycin, top products include Daratumumab, Cyclophosphamide, Ibrutinib, Pembrolizumab, Ustekinumab. View the complete Vama Lifecare Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mitomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Mitomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Vama Lifecare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 22 individual customs records matching Vama Lifecare Private Limited exporting Mitomycin, covering 18 formulations to 5 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 103+ countries, 456+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Mitomycin Export Data from Vama Lifecare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Vama Lifecare Private Limited's Mitomycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Vama Lifecare Private Limited
Full Company Profile →
14 products · $1.4M total trade · 3 categories
Mitomycin Stats
Company Overview
Top Products by Vama Lifecare Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Vama Lifecare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mitomycin. For current shipment-level data, contact TransData Nexus.